Clinical Trial Update: Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH) [Phase 3]

View source ↗

Summary

Phase III trial in anaplastic glioma without 1p/19q LOH is active/not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain and Central Nervous System Tumors

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Brain and Central Nervous System Tumors | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-09-11